Sage Drug Patent Portfolio

Sage owns 2 orange book drugs protected by 13 US patents Given below is the list of Sage's drug patents along with their expiration dates.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US10940156 Neuroactive steroids, compositions, and uses thereof 08 Mar, 2037
Active
US10251894 Anticonvulsant activity of steroids 27 Nov, 2033
Active
US10322139 Neuroactive steroid formulations and methods of treating CNS disorders 23 Jan, 2033
Active
US10117951 Sulfoalkyl ether cyclodextrin compositions 13 Mar, 2029
Active
US7635773 Sulfoalkyl ether cyclodextrin compositions 13 Mar, 2029
Active
US8410077 Sulfoalkyl ether cyclodextrin compositions 13 Mar, 2029
Active
US9200088 Sulfoalkyl ether cyclodextrin compositions 13 Mar, 2029
Active
US9750822 Sulfoalkyl ether cyclodextrin compositions 13 Mar, 2029
Active
US7935093 Disinfectant delivery system and method of providing alcohol-free disinfection 02 Oct, 2027
Active
US7427574 Non-woven wash cloth 25 Apr, 2026
Active
US7717889 Disinfectant delivery system and method of providing alcohol free disinfection 27 Feb, 2025 Expired
US7066916 Disinfectant delivery system, and method of providing alcohol-free disinfection 17 Feb, 2024 Expired
US7595021 Method of providing alcohol-free disinfection 12 May, 2023 Expired


Given below is the list of recent legal activities going on the following drug patents of Sage.

Activity Date Patent Number
Patent litigations
Payment of Maintenance Fee, 4th Year, Large Entity 30 Nov, 2022 US10322139
Payment of Maintenance Fee, 12th Year, Large Entity 19 Oct, 2022 US7935093
Payment of Maintenance Fee, 4th Year, Large Entity 21 Sep, 2022 US10251894
Payment of Maintenance Fee, 12th Year, Large Entity 03 Nov, 2021 US7717889
Payment of Maintenance Fee, 12th Year, Large Entity 17 Mar, 2021 US7595021
Recordation of Patent Grant Mailed 09 Mar, 2021 US10940156
Patent Issue Date Used in PTA Calculation 09 Mar, 2021 US10940156
Email Notification 18 Feb, 2021 US10940156
Issue Notification Mailed 17 Feb, 2021 US10940156
Dispatch to FDC 29 Jan, 2021 US10940156
Email Notification 18 Jan, 2021 US10940156
Mail Response to 312 Amendment (PTO-271) 18 Jan, 2021 US10940156
Response to Amendment under Rule 312 13 Jan, 2021 US10940156
Amendment after Notice of Allowance (Rule 312) 11 Jan, 2021 US10940156
Application Is Considered Ready for Issue 04 Jan, 2021 US10940156


Sage Drug Patents' Oppositions Filed in EPO

Sage drug patents have faced multiple oppositions in the European Patent Office. The earliest opposition was filed on Jul 08, 2020, by Dr. Schön, Neymeyr & Partner Patentanwälte Mbb. This opposition was filed on patent number EP13740743A. Click below to reveal the latest opposition data.


Application Filing Date Opposition Party Legal Status
Patent litigations
EP13740743A Jul, 2020 Dr. Schön, Neymeyr & Partner Patentanwälte mbB Granted and Under Opposition


Sage's Family Patents

Sage drugs have patent protection in a total of 31 countries. It's US patent count contributes only to 29.8% of its total global patent coverage. 2 countries have all of their patents expired or invalidated which has opened up potential generic launch opportunities in these countries. Click below to unlock the full patent family tree.

Family Patents



Sage Drug List

Given below is the complete list of Sage's drugs and the patents protecting them.


1. Chlorhexidine Gluconate

Chlorhexidine Gluconate is protected by 5 patents, out of which 3 have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US7935093 Disinfectant delivery system and method of providing alcohol-free disinfection 02 Oct, 2027
(1 year, 8 months from now)
Active
US7427574 Non-woven wash cloth 25 Apr, 2026
(3 months from now)
Active
US7717889 Disinfectant delivery system and method of providing alcohol free disinfection 27 Feb, 2025
(10 months ago)
Expired
US7066916 Disinfectant delivery system, and method of providing alcohol-free disinfection 17 Feb, 2024
(1 year, 10 months ago)
Expired
US7595021 Method of providing alcohol-free disinfection 12 May, 2023
(2 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Chlorhexidine Gluconate's drug page


2. Zulresso

Zulresso is protected by 8 patents, out of which none have expired yet. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US10940156 Neuroactive steroids, compositions, and uses thereof 08 Mar, 2037
(11 years from now)
Active
US10251894 Anticonvulsant activity of steroids 27 Nov, 2033
(7 years from now)
Active
US10322139 Neuroactive steroid formulations and methods of treating CNS disorders 23 Jan, 2033
(7 years from now)
Active
US10117951 Sulfoalkyl ether cyclodextrin compositions 13 Mar, 2029
(3 years from now)
Active
US7635773 Sulfoalkyl ether cyclodextrin compositions 13 Mar, 2029
(3 years from now)
Active
US8410077 Sulfoalkyl ether cyclodextrin compositions 13 Mar, 2029
(3 years from now)
Active
US9200088 Sulfoalkyl ether cyclodextrin compositions 13 Mar, 2029
(3 years from now)
Active
US9750822 Sulfoalkyl ether cyclodextrin compositions 13 Mar, 2029
(3 years from now)
Active

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Zulresso's drug page


Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List